Effect of cigarette smoking on renal function and vascular endothelium

Contributions to Nephrology

Volumn 130, Issue , 2000, Pages 45-52

  Remuzzi, Giuseppe ^a,b  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; GLYCERYL TRINITRATE; NITRIC OXIDE;

DRUG EFFECT; HUMAN; KIDNEY; KIDNEY CIRCULATION; METABOLISM; PATHOPHYSIOLOGY; REVIEW; SMOKING; SMOOTH MUSCLE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ENDOTHELINS; ENDOTHELIUM, VASCULAR; HUMANS; KIDNEY; MUSCLE, SMOOTH; NITRIC OXIDE; NITROGLYCERIN; RENAL CIRCULATION; SMOKING; VASOCONSTRICTION; VASODILATION;

EID: 0033648430     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060041     Document Type: Article

References (37)

1. Hammond EC, Horn D: Smoking and death rates: Report of forty-four months of follow-up of 187,783 men. II. Death rates by cause. J Am Med Assoc 1958;166:1294-1308.
2. Gambara V, Ruggenenti P, Perna A, On behalf of the Bergamo Diabetic Nephropathy Study Group: Smoking is the strongest predictor of mortality in non-insulin-dependent diabetes (NIDD) (abstract). J Am Soc Nephrol 1997;8:137A.
3. Auerbach O, Carter HW, Garfinkel L, Hammond EC: Cigarette smoking and coronary artery disease: A macroscopic and microscopic study. Chest 1976;70:697-705.
4. Auerbach O, Hammond EC, Garfinkel L: Thickening of walls of arterioles and small arteries in relation to age and smoking habits. N Engl J Med 1968;278:980-984.
5. Asmussen I: Effects of maternal smoking on the fetal cardiovascular system. Cardiovasc Med 1979;4:777-790.
6. Salonen TJ, Salonen R: Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993;87(suppl 11):56-65.
7. Moritz AR, Oldt MR: Arteriolar sclerosis in hypertensive and non-hypertensive individuals. Am J Pathol 1937;13:679-728.
8. Black HR, Zeevi GR, Silten RM, Smith GJW: Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron 1983;34:173-179.
9. Gambaro G, Verlato F, Budakovic A, Casara D, Saladini G, Del Prete D, Bertaglia G, Masiero M, Checchetto S, Baggio B: Renal impairment in chronic cigarette smokers. J Am Soc Nephrol 1998;9:562-567.
10. Franek E, Benk U, Reinbold F, Fliser D, Clorius J, Ritz E: Influence of smoking on renal function (abstract). Nephrol Dial Transplant 1996;11:A65.
11. Muhlauser I: Cigarette smoking and diabetes: An update. Diabet Med 1994;11:336-341.
12. Dieperink H, Perico N, Remuzzi G: Cyclosporine/tacrolimus (FK-506); in De Broe ME, Porter GA, Bennett WM, Verpooten GA (eds): Clinical Nephrotoxins. Renal Injury from Drugs and Chemicals. Dordrecht, Kluwer Academic, 1998, pp 275-300.
13. Remuzzi G, Perico N: Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int 1995;48(suppl 52):S-70-S-74.
14. Perico N, Dadan J, Remuzzi G: Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. J Am Soc Nephrol 1990;1:76-83.
15. Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I, Hoover RL: Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990;37:1487-1491.
16. Bertani T, Ferrazzi P, Schieppati A, Ruggenenti P, Gamba A, Parenzan L, Mecca G, Perico N, Imberti O, Remuzzi A, Remuzzi G: Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 1991;40:243-250.
17. Perico N, Ruggenenti P, Gaspari F, Mosconi L, Benigni A, Amuchastegui CS, Gasparini F, Remuzzi G: Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 1992;54:56-60.
18. Myers BD, Newton L: Cyclosporine-induced chronic nephropathy: An obliterative microvascular renal injury. J Am Soc Nephrol 1995;2:S45-S52.
19. Hostetter TH, Olson JL, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 1981;241:F85-F93.
20. Zhu B-Q, Sun Y-P, Sievers RE, Isenberg WM, Glantz SA, Parmley WW: Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 1993;21:225-232.
21. Penn A, Chen L-C, Snyder CA: Inhalation of steady-state sidestream smoke from one cigarette promotes arteriosclerotic plaque development. Circulation 1994;90:1363-1367.
22. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-809.
23. Moore S: Thromboatherosclerosis in normolipemic rabbits: A result of continued endothelial damage. Lab Invest 1973;29:478-487.
24. Fish RD, Nabel EG, Selwyn AP: Responses of coronary arteries or cardiac transplant patients to acetylcholine. J Clin Invest 1988;81:21-31.
25. Celermajer DS, Adams MR, Clarkson BSP, Robinson BSJ, McCredie RNR, Donald A, Deanfield JE: Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996;334:150-154.
26. Remuzzi G, Benigni A: Endothelins in the control of cardiovascular and renal function. Lancet 1993;342:589-593.
27. Kohan DE: Endothelins in the kidney: Physiology and pathophysiology. Am J Kidney Dis 1993;22:493-510.
28. Lerman A, Hildebrand FL, Aarhus LL, Burnett J: Endothelin has biological actions at pathophysiological concentrations. Circulation 1991;83:1808-1814.
29. Haynes GW, Webb DJ: The endothelin family of peptides: Local hormones with diverse roles in health and disease? Clin Sci 1993;84:485-500.
30. Cryer PE, Haymond MW, Santiago JV, Shah SD: Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-577.
31. Nadler JL, Velasco JS, Horton R: Cigarette smoking inhibits prostacyclin formation. Lancet 1983; i:1248-1250.
32. Benigni A, Remuzzi G: Endothelin antagonists. Lancet 1999;353:133-138.
33. Kiowski W, Linder L, Stoschitzky K, Pfisterer M, Burckhardt D, Burkart F, Buhler FR: Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994;90:27-34.
34. Nitenberg A, Antony I, Foult JM: Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings. Am J Med 1993;95:71-77.
35. Celermajer DS, Sorensen KE, Georgakopoulos D, Buller C, Thomas O, Robinson J, Deanfield JE: Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149-2155.
36. Shears II BL, Kawaharada N, Tzeng E, Billiar TR, Watkins SC, Kovesdi I, Lizonova J, Pham SM: Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest 1997;100:2035-2042.
37. Benigni A, Remuzzi G: The renoprotective potential of endothelin receptor antagonists. Exp Opin Ther Patents 1997;7:139-149.